Sunicine 50mg Capsule (Sunitinib)

The Sunicine 50mg capsule (Sunitinib) is a targeted anticancer medicine that contains Sunitinib as an active ingredient. It is used in the treatment of kidney cancer, pancreatic neuroendocrine tumors and gastrointestinal stromal tumor. The medicine belongs to the drug class of tyrosine kinase inhibitor. It works by blocking the specific protein called tyrosine kinase that drives cancer growth and the formation of new blood vessels, leading to tumor. By inhibiting these pathways, it helps slow or decrease the growth and spread of cancer cells. The Sunitinib 50mg capsule is typically prescribed as a standalone targeted therapy but not in specific combination therapy.

The capsule must be taken orally and swallowed whole with water and should not be crushed, chewed, or opened. The prescribed dose and duration of the Sunitinib 50mg capsule depend on the patient's condition and response to treatment. It can also be taken with or without food. Patients are advised not to change the dosage and timings prescribed by the doctors because it can cause severe side effects.

Common side effects include tiredness, weakness, nausea, vomiting, diarrhea, loss of appetite, abdominal discomfort, mouth sores, changes in taste, skin discolouration, and hand-foot syndrome. A few patients can undergo severe side effects, including severe bleeding, heart problems, high blood pressure, liver damage, kidney problems and thyroid dysfunction. Most of the Sunitinib 50mg capsule side effects can leave when the body adapts to the medicine. However, report to your doctor if you experience serious side effects.

The medicine may harm an unborn baby and should not be used during pregnancy. Inform your doctor before undergoing surgery or dental procedures because the drug may affect wound healing. Patients must list all medicines, supplements, and herbal products that they are taking. The Sunitinib 50mg capsule must be used under medical oversight or medical supervision only. Attend regular tests and follow-ups to monitor the medicine response and reduce side effects. Before making any adjustments, changing the dose, or stopping the treatment, consult with your doctor to maximize the benefit.

Kidney Cancer and Gastrointestinal Stromal Tumor

Being aware of side effects of the Sunicine 50mg capsule (sunitinib) can assist you in preventing any problems during treatment. Please contact your doctor in case these side effects continue or become severe:

● Reduced appetite

● Mucositis

● Hypertension

● Hand-foot syndrome

● Bleeding problems

● Nausea

● Vomiting

● Weakness

●Fatigue

● Diarrhea

● Taste changes​

The Sunicine 50mg tablet should be taken under proper guidance. The doctor recommends taking this tablet with or without food at the fixed time every day.

Do not skip or stop the medication without consulting a doctor.

● Rini, B. I. (2007). Sunitinib. Expert opinion on pharmacotherapy, 8(14), 2359-2369.

● Chow, L. Q., & Eckhardt, S. G. (2007). Sunitinib: from rational design to clinical efficacy. Journal of clinical oncology, 25(7), 884-896.

●Deeks, E. D., & Keating, G. M. (2006). Sunitinib. Drugs, 66(17), 2255-2266.

● Faivre, S., Demetri, G., Sargent, W., & Raymond, E. (2007). Molecular basis for sunitinib efficacy and future clinical development. Nature reviews Drug discovery, 6(9), 734-745.

● Motzer, R. J., Rini, B. I., Bukowski, R. M., Curti, B. D., George, D. J., Hudes, G. R., ... & Michaelson, M. D. (2006). Sunitinib in patients with metastatic renal cell carcinoma. Jama, 295(21), 2516-2524.​